6173 results
Cited 67 times since 2005 (3.5 per year)
source: EuropePMC
Radiology,
Volume 237, Issue 3, 1 1 2005, Pages 868-871
Corrected tetralogy of Fallot: delayed enhancement in right ventricular outflow tract.
Oosterhof T, Mulder BJ, Vliegen HW, de Roos A
Purpose: To evaluate retrospectively the presence of fibrosis and largest diameter of the right ventricular outflow tract (RVOT) by using delayed enhancement magnetic resonance (MR) imaging in patients who had undergone initial correction for tetralogy of Fallot. Materials and methods: MR imaging was performed in 24 consecutive patients (16 male, eight female; mean age, 25 years; age range, 13-47 years) with corrected tetralogy of Fallot. The study protocol was approved by the local ethics commi...
Abstract
Nederlands tijdschrift voor geneeskunde,
Volume 149, Issue 50, 1 1 2005, Pages 2773-2774
[The availability of only one statin is inadequate].
Jukema JW
When looking at the history of the prescription of a new class of drugs e.g. the statin, it is clear that for optimal use with regard to efficacy, areas of indication and safety, the continuous development of new compounds within this class was very advantageous. Competition between compounds is essential for providing best patient care. Thus the availability of only one statin was and continues to be inadequate for this purpose.
Abstract
Cited 57 times since 2005 (2.9 per year)
source: EuropePMC
FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Volume 19, Issue 14, 1 1 2005, Pages 1998-2004
Tumor necrosis factor-alpha plays an important role in restenosis development.
Monraats PS, Pires NM, Schepers A, Agema WR, Boesten LS, de Vries MR, Zwinderman AH, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, 't Hart LM, Frants RR, Quax PH, van Vlijmen BJ, Havekes LM, van der Laarse A, van der Wall EE, Jukema JW
Genetic factors appear to be important in the restenotic process after percutaneous coronary intervention (PCI), as well as in inflammation, a pivotal factor in restenosis. TNFalpha, a key regulator of inflammatory responses, may exert critical influence on the development of restenosis after PCI. The GENetic DEterminants of Restenosis (GENDER) project included 3104 patients who underwent a successful PCI. Systematic genotyping for six polymorphisms in the TNFalpha gene was performed. The role o...
Abstract
Cited 18 times since 2005 (0.9 per year)
source: EuropePMC
Heart rhythm,
Volume 2, Issue 12, 1 1 2005, Pages 1365-1368
Syndactyly and long QT syndrome (CaV1.2 missense mutation G406R) is associated with hypertrophic cardiomyopathy.
Lo-A-Njoe SM, Wilde AA, van Erven L, Blom NA
Abstract
Cited 3 times since 2005 (0.2 per year)
source: EuropePMC
Nederlands tijdschrift voor geneeskunde,
Volume 149, Issue 51, 1 1 2005, Pages 2837-2840
[Percutaneous coronary intervention with stent placement versus bypass operation in symptomatic multiple-vessel disease; lessons from an observational study].
van der Hoeven BL, Schalij MJ, van der Wall EE
In a large observational study comparing percutaneous coronary intervention (PCI) using stent implantation with coronary-artery bypass grafting (CABG), 3-year survival was better after CABG than after PCI with stenting. This was particularly true in patients with triple-vessel disease, and for patients with two-vessel disease with involvement ofthe proximal left anterior descending artery (LAD). Potential explanations for this finding are that with CABG 'future' culprit lesions are byp...
Abstract
Cited 189 times since 2005 (9.7 per year)
source: EuropePMC
The American journal of cardiology,
Volume 97, Issue 2, 28 4 2005, Pages 260-263
Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy.
Bleeker GB, Bax JJ, Fung JW, van der Wall EE, Zhang Q, Schalij MJ, Chan JY, Yu CM
Currently, a clear definition of response to cardiac resynchronization therapy (CRT) is still lacking, and clinical and echocardiographic end points are used. It is also unclear whether patients with clinical responses also improve in echocardiographic end points (and vice versa). To better understand and define response to CRT, the relation between improvement in clinical and echocardiographic parameters was evaluated in 144 patients.
Abstract
Cited 1 times since 2005 (0.1 per year)
source: EuropePMC
The international journal of cardiovascular imaging,
Volume 22, Issue 2, 25 4 2005, Pages 167-169
Failure to decrease blood pressure during sleep: non-dippers are among us.
Steendijk P
Abstract
Cited 144 times since 2005 (7.4 per year)
source: EuropePMC
Arteriosclerosis, thrombosis, and vascular biology,
Volume 26, Issue 2, 23 4 2005, Pages 340-346
Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis.
de Nooijer R, Verkleij CJ, von der Thüsen JH, Jukema JW, van der Wall EE, van Berkel TJ, Baker AH, Biessen EA
Background: Matrix metalloproteinase-9 (MMP-9) is involved in atherosclerosis and elevated MMP-9 activity has been found in unstable plaques, suggesting a crucial role in plaque rupture. This study aims to assess the effect of MMP-9 on plaque stability in apolipoprotein E-deficient mice at different stages of plaque progression. Methods and results: Atherosclerotic lesions were elicited in carotid arteries by perivascular collar placement. MMP-9 overexpression in intermediate or advanced plaques...
Abstract
Pulmonary pharmacology & therapeutics,
Volume 19, Issue 6, 18 3 2005, Pages 397-403
Clinically masked increases in bronchial inflammation in guideline-treated persistent asthma.
Koopmans JG, Lutter R, Jansen HM, van der Zee JS
Background: Current guidelines generally recommend a combination of inhaled corticosteroids and a Beta2-agonist for persistent asthma. The adjustment of anti-inflammatory therapy in persistent asthma is advised to be guided mainly by the presence of symptoms. Objective: To investigate whether clinically masked increases in bronchial inflammation occur in guideline-treated, persistent asthma following allergen exposure. Methods: After a 4-week steroid-run-in period (fluticasone 250 microg twice d...
Abstract
Cited 21 times since 2005 (1.1 per year)
source: EuropePMC
Basic research in cardiology,
Volume 101, Issue 1, 11 2 2005, Pages 36-42
Suppression of physiological cardiomyocyte proliferation in the rat pup after neonatal glucocorticosteroid treatment.
de Vries WB, Bal MP, Homoet-van der Kraak P, Kamphuis PJ, van der Leij FR, Baan J, Steendijk P, de Weger RA, van Bel F, van Oosterhout MF
Background: Glucocorticosteroids (mostly dexamethasone) are widely used to prevent chronic lung disease in premature infants. Neonatal rats treated with dexamethasone have been shown to have reduced cardiac mass and cardiomyocyte hypertrophy, suggesting a lower number of cardiomyocytes at adult age, and a severely reduced life expectancy. In the present study we tested the hypothesis that a lower number of cardiomyocytes in later life is caused by a reduced cardiomyocyte proliferation and/or by...
Abstract
Cited 5 times since 2005 (0.3 per year)
source: EuropePMC
Heart, lung & circulation,
Volume 14 Suppl 2, 7 1 2005, Pages S8-13
Assessment of myocardial viability in ischemic cardiomyopathy.
Bax JJ
The number of patients with ischemic cardiomyopathy has increased extensively over recent years. Therapies include medical treatment, cardiac transplantation, cardiac resynchronization therapy and surgery. In the diagnostic and prognostic work-up, the assessment of myocardial viability has become more important over time. In particular, patients with viable myocardium can improve in LV function after revascularization; this will not occur in patients without viable tissue. In view of the high ri...
Abstract
Cited 78 times since 2005 (4 per year)
source: EuropePMC
Circulation,
Volume 112, Issue 20, 7 1 2005, Pages 3058-3065
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).
Packard CJ, Ford I, Robertson M, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, PROSPER Study Group
Background: Statins are important in vascular disease prevention in the elderly. However, the best method of selecting older patients for treatment is uncertain. We assessed the role of plasma lipoproteins as predictors of risk and of treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). Method and results: The association of LDLc and HDLc with risk was examined in the 5804 70- to 82-year-old subjects of PROSPER. Baseline LDLc showed no relation to risk of t...
Abstract
Cited 15 times since 2005 (0.8 per year)
source: EuropePMC
The American journal of cardiology,
Volume 97, Issue 1, 4 1 2005, Pages 1-6
Prognostic implications of a normal stress technetium-99m-tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularization.
Schinkel AF, Elhendy A, Bax JJ, van Domburg RT, Huurman A, Valkema R, Biagini E, Rizzello V, Feringa HH, Krenning EP, Simoons ML, Poldermans D
Previous studies have shown a good outcome for patients who present with normal findings on stress myocardial perfusion imaging. Currently, the prognostic implications of a normal study in patients who have a history of coronary artery disease (CAD) are not clear. This study investigated the long-term prognosis after a normal finding on stress technetium-99m (Tc-99m)-tetrofosmin single-photon emission computed tomography in patients with a history of CAD. The study included 147 consecutive patie...
Abstract
Cited 6 times since 2005 (0.3 per year)
source: EuropePMC
Acta physiologica Scandinavica,
Volume 185, Issue 3, 1 1 2005, Pages 181-191
Left ventricular pressure-volume relationships during normal growth and development in the adult rat--studies in 8- and 50-week-old male Wistar rats.
Bal MP, de Vries WB, van der Leij FR, van Oosterhout MF, Baan J, van der Wall EE, van Bel F, Steendijk P
Aims: Left ventricular (LV) pressure-volume relations provide relatively load-independent indexes of systolic and diastolic LV function, but few data are available on pressure-volume relations during growth and development in the normal adult heart. Furthermore, to quantify intrinsic ventricular function the indexes should be normalized for heart weight. However, in many studies the indexes are reported in absolute terms, or body weight-correction is used as a surrogate for heart weight-correcti...
Abstract
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
Volume 13, Issue Suppl 2, 1 1 2005, Pages 12-13
Acute coronary syndrome without ST elevation: what is new?: Stockholm, 4 September 2005.
Beeres SL
Abstract
Cited 14 times since 2005 (0.7 per year)
source: EuropePMC
European journal of nuclear medicine and molecular imaging,
Volume 32, Issue 11, 1 1 2005, Pages 1337-1347
Multislice CT coronary angiography: how to do it and what is the current clinical performance?
Cademartiri F, Schuijf JD, Mollet NR, Malagutti P, Runza G, Bax JJ, de Feyter PJ
The introduction of multislice computed tomography (MSCT) has allowed non-invasive coronary angiography. Although widely applied, extensive information on technical details of the technique is lacking. This survey offers detailed information on patient preparation, data acquisition, reconstruction and interpretation. In addition, a summary of the available studies using MSCT for non-invasive angiography is provided. Based on pooled analysis of direct comparisons between MSCT and invasive angiogr...
Abstract
Future cardiology,
Volume 1, Issue 6, 1 1 2005, Pages 701-704
Prevention of perioperative cardiovascular complications in non-cardiac surgery: the future role of statins.
Schouten O, Bax JJ, Poldermans D
Abstract
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
Volume 13, Issue Suppl 2, 1 1 2005, Pages 16-17
Insights into the management of atrial fibrillation in clinical practice in Europe: results of the Euro Heart Survey on atrial fibrillation: Stockholm, 5 September 2005.
Tops LF
Abstract
Cited 38 times since 2005 (1.9 per year)
source: EuropePMC
Current medical research and opinion,
Volume 21, Issue 11, 1 1 2005, Pages 1865-1874
LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
Jukema JW, Liem AH, Dunselman PH, van der Sloot JA, Lok DJ, Zwinderman AH
Background: The ratio of low-density lipoprotein cholesterol and high-density lipoprotein cholesterol (LDL-C/HDL-C) is a reliable predictor of cardiovascular risk. Low HDL-C levels in patients with coronary artery disease are associated with a high risk for cardiovascular events. Objectives: This study compared the effects of rosuvastatin and atorvastatin on the LDL-C/HDL-C. Methods: Patients aged 40-80 years with established cardiovascular disease and HDL-C < 1.0 mmol/L (< 40 mg/dL) enter...
Abstract
Nederlands tijdschrift voor geneeskunde,
Volume 149, Issue 48, 1 1 2005, Pages 2655-2658
[The practice guideline 'Heart failure' (first revision) from the Dutch College of General Practitioners; a response from the perspective of cardiology].
Ypenburg C, Schalij MJ, van der Wall EE
The Dutch College of General Practitioners' practice guideline 'Heart failure' provides a clear insight into the history, diagnosis and treatment of patients with chronic heart failure. The revised guideline does however warrant some minor comments. It suggests that an elevated BNP value contributes towards the diagnosis of heart failure, however taking into account the high negative predictive value, BNP should, for the time being at least, only act as an 'instrument of excl...
Abstract
